Current through Register Vol. 43, No. 49, December 5, 2024
Section 28-35-311 - Human use of particle acceleratorsIn addition to the requirements set forth in part 2, the registrant shall:
(A) Whenever deemed necessary by the department, the registrant shall appoint a medical committee of at least three (3) members to evaluate all proposals for research, diagnostic, and therapeutic use of a particle accelerator. Membership of the committee should include physicians expert in internal medicine, hematology, therapeutic radiology, and a person experienced in depth dose calculations and protection against radiation; (B) The individuals designated as the users shall have substantial training and experience in deep therapy techniques or in the use of particle accelerations to treat humans; and (C) The user must be a physician. Kan. Admin. Regs. § 28-35-311
Authorized by K.S.A. 1975 Supp. 48-1607; effective May 1, 1976.